n-acetylneuraminic acid has been researched along with Autoimmune Thrombocytopenia in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 8 (66.67) | 24.3611 |
| 2020's | 3 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Cheng, Y; Ji, L; Li, F; Ou, Y; Shao, X; Xu, P; Zhan, Y; Zhuang, X | 1 |
| Cairo, CW; Hollenhorst, MA; Kuter, DJ; Tiemeyer, KH | 1 |
| Álvarez Román, MT; Butta, NV; Fernández Bello, I; Hernández, D; Jiménez Yuste, V; Justo Sanz, R; Martín Salces, M; Monzón Manzano, E; Rivas Pollmar, I; Valor, L | 1 |
| Fan, KL; Geng, SY; Gong, J; Hou, M; Huang, L; Li, MF; Li, X; Li, XL; Liang, YF; Lin, P; Liu, LY; Peng, J; Qiu, JH; Tian, XH; Wang, LN; Wang, WT; Yu, QX; Yu, YY; Zhang, XL; Zhang, YF | 1 |
| Berrueco, R; Campos, RM; Corral, J; de la Morena-Barrio, ME; Fuentes, I; Galvez, E; Gonzalez, N; Gonzalez-Lopez, TJ; Gonzalez-Porras, JR; Lozano, ML; Miñano, A; Mingot-Castellano, ME; Revilla, N; Velasco, F; Vicente, V | 1 |
| Fillatreau, S | 1 |
| Avery, W; Bhatnagar, N; Bosques, CJ; Cochran, E; Garofalo, K; Kaundinya, GV; Lansing, JC; Ling, L; Manning, AM; Meador, JW; Meccariello, R; Medeiros, A; Mekala, D; Nimmerjahn, F; Ortiz, D; Rutitzky, L; Sarvaiya, H; Schultes, BC; Schwab, I; Tyler, S; Washburn, N | 1 |
| Baerenwaldt, A; Biburger, M; Nimmerjahn, F | 1 |
| Aalberse, RC; Bloem, J; Derksen, NI; Guhr, T; Koenderman, AH; Rispens, T; Wuhrer, M | 1 |
| Branch, DR; Käsermann, F; Katsman, Y; Leontyev, D; Ma, XZ; Miescher, S | 1 |
| Biburger, M; Krönke, G; Nimmerjahn, F; Schett, G; Schwab, I | 1 |
| Anthony, RM; Ashline, DJ; Nimmerjahn, F; Paulson, JC; Ravetch, JV; Reinhold, VN | 1 |
2 review(s) available for n-acetylneuraminic acid and Autoimmune Thrombocytopenia
| Article | Year |
|---|---|
New insights into the glycobiology of immune thrombocytopenia.
Topics: Antiviral Agents; Blood Platelets; Glycomics; Humans; N-Acetylneuraminic Acid; Neuraminidase; Polysaccharides; Purpura, Thrombocytopenic, Idiopathic; Thrombocytopenia | 2023 |
Mechanisms of action of intravenous immunoglobulins.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Autoantibodies; Autoimmune Diseases; Clinical Trials as Topic; Dendritic Cells; Humans; Immunoglobulin G; Immunoglobulin Variable Region; Immunoglobulins, Intravenous; Macrophages; Mice; Monocytes; N-Acetylneuraminic Acid; Purpura, Thrombocytopenic, Idiopathic; Rats; Receptors, Fc | 2010 |
1 trial(s) available for n-acetylneuraminic acid and Autoimmune Thrombocytopenia
| Article | Year |
|---|---|
Platelet desialylation is a novel mechanism and a therapeutic target in thrombocytopenia during sepsis: an open-label, multicenter, randomized controlled trial.
Topics: Adult; Antibody Specificity; Asialoglycoprotein Receptor; Autoantibodies; Biomarkers; Blood Platelets; Drug Monitoring; Female; Flow Cytometry; Humans; Immunoglobulin Fc Fragments; Middle Aged; N-Acetylneuraminic Acid; Plant Lectins; Platelet Glycoprotein GPIb-IX Complex; Platelet Glycoprotein GPIIb-IIIa Complex; Purpura, Thrombocytopenic, Idiopathic; Sepsis; Thrombocytopenia; Treatment Outcome | 2017 |
9 other study(ies) available for n-acetylneuraminic acid and Autoimmune Thrombocytopenia
| Article | Year |
|---|---|
A bibliometric analysis of primary immune thrombocytopenia from 2011 to 2021.
Topics: Bibliometrics; Blood Platelets; China; Humans; N-Acetylneuraminic Acid; Purpura, Thrombocytopenic, Idiopathic | 2023 |
Platelet and immune characteristics of immune thrombocytopaenia patients non-responsive to therapy reveal severe immune dysregulation.
Topics: Adult; Aged; Apoptosis; Blood Platelets; Caspases; Cross-Sectional Studies; Cytokines; Female; Humans; Killer Cells, Natural; Lymphocyte Count; Male; Middle Aged; Monocytes; N-Acetylneuraminic Acid; Platelet Activation; Polysaccharides; Prospective Studies; Purpura, Thrombocytopenic, Idiopathic; Receptors, Thrombopoietin; T-Lymphocytes, Regulatory; Treatment Failure | 2020 |
Multirefractory primary immune thrombocytopenia; targeting the decreased sialic acid content.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Female; Humans; Male; Middle Aged; N-Acetylneuraminic Acid; Prospective Studies; Purpura, Thrombocytopenic, Idiopathic; Young Adult | 2019 |
Sweetened antibodies against humoral autoimmunity: sialylated antibodies are required for IVIg-mediated therapy.
Topics: Animals; Autoantibodies; Humans; Immunity, Humoral; Immunoglobulin G; Immunoglobulins, Intravenous; Mice; N-Acetylneuraminic Acid; Purpura, Thrombocytopenic, Idiopathic | 2014 |
Controlled tetra-Fc sialylation of IVIg results in a drug candidate with consistent enhanced anti-inflammatory activity.
Topics: Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Blister; Disease Models, Animal; Drug Design; Epidermolysis Bullosa Acquisita; Glycosylation; HEK293 Cells; Humans; Immunoglobulin Fab Fragments; Immunoglobulins, Intravenous; Mice; N-Acetylneuraminic Acid; Purpura, Thrombocytopenic, Idiopathic; Receptors, Fc; Tissue Distribution; Treatment Outcome | 2015 |
Enrichment of sialylated IgG by lectin fractionation does not enhance the efficacy of immunoglobulin G in a murine model of immune thrombocytopenia.
Topics: Animals; Chemical Fractionation; Chromatography, Affinity; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Glycosylation; Humans; Immunoglobulin G; Immunoglobulins, Intravenous; Immunomodulation; Mass Spectrometry; Mice; N-Acetylneuraminic Acid; Plant Lectins; Platelet Count; Purpura, Thrombocytopenic, Idiopathic; Rats; Ribosome Inactivating Proteins | 2011 |
Sialylation-independent mechanism involved in the amelioration of murine immune thrombocytopenia using intravenous gammaglobulin.
Topics: Animals; Asparagine; Disease Models, Animal; Immunoglobulin Fab Fragments; Immunoglobulin Fc Fragments; Immunoglobulins, Intravenous; Immunologic Factors; Mice; Mice, Inbred BALB C; N-Acetylneuraminic Acid; Plant Lectins; Platelet Count; Polysaccharides; Purpura, Thrombocytopenic, Idiopathic; Receptors, IgG; Ribosome Inactivating Proteins; RNA, Messenger | 2012 |
IVIg-mediated amelioration of ITP in mice is dependent on sialic acid and SIGNR1.
Topics: Animals; Antibodies, Neutralizing; Autoantibodies; Blood Platelets; Cell Adhesion Molecules; Female; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Lectins, C-Type; Male; Mice; Mice, Knockout; N-Acetylneuraminic Acid; Phagocytosis; Purpura, Thrombocytopenic, Idiopathic; Receptors, Cell Surface; Splenectomy | 2012 |
Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Autoimmune Diseases; Carbohydrate Conformation; Galactose; Glycosylation; Humans; Immunoglobulin Fc Fragments; Immunoglobulin G; Immunoglobulins, Intravenous; Mice; Mice, Inbred C57BL; Mice, Inbred NOD; N-Acetylneuraminic Acid; Polysaccharides; Purpura, Thrombocytopenic, Idiopathic; Receptors, Fc; Recombinant Proteins | 2008 |